The Inhibitory Effect of Gut Microbiota and Its Metabolites on Colorectal Cancer.
Gut microbiota
anticancer effect
bacteria components
colorectal cancer
gut microbial metabolites
Journal
Journal of microbiology and biotechnology
ISSN: 1738-8872
Titre abrégé: J Microbiol Biotechnol
Pays: Korea (South)
ID NLM: 9431852
Informations de publication
Date de publication:
28 Nov 2020
28 Nov 2020
Historique:
received:
17
02
2020
revised:
24
05
2020
accepted:
31
05
2020
pubmed:
12
6
2020
medline:
7
7
2021
entrez:
12
6
2020
Statut:
ppublish
Résumé
Colorectal cancer (CRC) is regarded as one of the most common and deadly forms of cancer. Gut microbiota is vital to retain and promote several functions of intestinal. Although previous researches have shown that some gut microbiota have the abilities to inhibit tumorigenesis and prevent cancer from progressing, they have not yet clearly identified associative mechanisms. This review not only concentrates on the antitumor effects of metabolites produced by gut microbiota, for example, SCFA, ferrichrome, urolithins, equol and conjugated linoleic acids, but also the molecules which constituted the bacterial cell wall have the antitumor effect in the host, including lipopolysaccharide, lipoteichoic acid, β-glucans and peptidoglycan. The aim of our review is to develop a possible therapeutic method, which use the products of gut microbiota metabolism or gut microbiota constituents to help treat or prevent colorectal cancer.
Identifiants
pubmed: 32522960
pii: jmb.2002.02032
doi: 10.4014/jmb.2002.02032
pmc: PMC9728159
doi:
Substances chimiques
Antineoplastic Agents
0
Linoleic Acids
0
Ferrichrome
15630-64-5
Equol
531-95-3
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1607-1613Références
Gut. 2016 Jan;65(1):63-72
pubmed: 25431456
Rev Col Bras Cir. 2017 Nov-Dec;44(6):567-573
pubmed: 29267553
Cancer Epidemiol Biomarkers Prev. 2010 Jan;19(1):148-58
pubmed: 20056634
Nat Rev Microbiol. 2017 Aug;15(8):465-478
pubmed: 28529325
J Nutr Biochem. 2015 Oct;26(10):1022-8
pubmed: 26026836
Microb Pathog. 2018 Oct;123:183-189
pubmed: 30017942
JPEN J Parenter Enteral Nutr. 2016 Nov;40(8):1114-1121
pubmed: 25917895
Medicine (Baltimore). 2018 Sep;97(36):e11678
pubmed: 30200062
J Nutr Biochem. 2013 Aug;24(8):1415-22
pubmed: 23849454
Int J Cancer. 2006 Feb 1;118(3):571-6
pubmed: 16106401
J Cell Physiol. 2019 Jun;234(6):8008-8018
pubmed: 30317594
Front Immunol. 2017 Nov 17;8:1553
pubmed: 29209314
Front Genet. 2015 Apr 20;6:148
pubmed: 25941533
Beijing Da Xue Xue Bao Yi Xue Ban. 2017 Jun 18;49(3):383-387
pubmed: 28628136
Int J Mol Sci. 2015 Apr 02;16(4):7493-519
pubmed: 25849657
Nutrients. 2019 Feb 28;11(3):
pubmed: 30823406
In Vivo. 2015 May-Jun;29(3):359-63
pubmed: 25977381
Cell. 2014 Jul 17;158(2):288-299
pubmed: 25036629
ANZ J Surg. 2019 Sep;89(9):1091-1096
pubmed: 30485627
Cancer Res. 2003 Dec 15;63(24):9023-31
pubmed: 14695221
Nat Commun. 2016 Aug 10;7:12365
pubmed: 27507542
Pol J Microbiol. 2013;62(3):223-35
pubmed: 24459827
Appl Microbiol Biotechnol. 2017 Jan;101(1):47-64
pubmed: 27888332
Nature. 2012 Nov 8;491(7423):254-8
pubmed: 23034650
Curr Allergy Asthma Rep. 2013 Feb;13(1):19-26
pubmed: 23054627
Oncol Rep. 2019 Mar;41(3):1691-1699
pubmed: 30569144
Nutr Rev. 2017 Apr 1;75(4):286-305
pubmed: 28402523
CA Cancer J Clin. 2020 Jan;70(1):7-30
pubmed: 31912902
Pol Przegl Chir. 2012 Feb;84(2):86-92
pubmed: 22487741
Eur J Nutr. 2014 Apr;53(3):853-64
pubmed: 24077694
Nutrients. 2017 Jan 01;9(1):
pubmed: 28045428
Probiotics Antimicrob Proteins. 2019 Sep;11(3):857-864
pubmed: 29682678
Crit Rev Food Sci Nutr. 2012;52(6):488-513
pubmed: 22452730
Gut. 2017 Jan;66(1):70-78
pubmed: 26408641
Mol Carcinog. 2018 Feb;57(2):193-200
pubmed: 28976622
Nutr Cancer. 2012;64(7):1103-11
pubmed: 23061912
Ann Gastroenterol. 2016 Jan-Mar;29(1):56-62
pubmed: 26752951
Methods Mol Biol. 2018;1856:35-55
pubmed: 30178245
Int J Oncol. 2014 Mar;44(3):830-7
pubmed: 24430613
Semin Oncol. 2016 Feb;43(1):97-106
pubmed: 26970128
Nutr Cancer. 2011;63(4):653-62
pubmed: 21598179
J Clin Invest. 2007 Aug;117(8):2197-204
pubmed: 17657310
BMJ Open Gastroenterol. 2017 Jul 3;4(1):e000145
pubmed: 28944067
Nat Rev Microbiol. 2014 Oct;12(10):661-72
pubmed: 25198138
Nat Commun. 2015 Apr 01;6:6734
pubmed: 25828455
Curr Drug Metab. 2013 Nov;14(9):994-1008
pubmed: 24160296
Hum Vaccin Immunother. 2017 Aug 3;13(8):1741-1750
pubmed: 28575585
Gut. 2000 Nov;47(5):646-52
pubmed: 11034580
Front Microbiol. 2015 Nov 26;6:1317
pubmed: 26635778
Sci Rep. 2018 Apr 10;8(1):5731
pubmed: 29636539
Biomed Res Int. 2018 Feb 7;2018:2871710
pubmed: 29568745
Annu Rev Genomics Hum Genet. 2017 Aug 31;18:65-86
pubmed: 28375652
J Gastroenterol Hepatol. 2019 Jul;34(7):1182-1192
pubmed: 30357910
Cell. 2016 Jun 2;165(6):1332-1345
pubmed: 27259147
Physiol Behav. 2008 May 23;94(2):276-84
pubmed: 18222501
World J Gastroenterol. 2015 Jul 21;21(27):8238-48
pubmed: 26217075
Biomol Ther (Seoul). 2015 Mar;23(2):134-40
pubmed: 25767681
J Nutr. 2003 Aug;133(8):2675-81
pubmed: 12888657
Microb Pathog. 2017 Oct;111:193-197
pubmed: 28867631
Int J Food Microbiol. 2010 Jul 31;141 Suppl 1:S53-9
pubmed: 20447709
Cell Metab. 2011 May 4;13(5):517-26
pubmed: 21531334
Tumour Biol. 2017 Jun;39(6):1010428317711311
pubmed: 28639907
Immunopharmacol Immunotoxicol. 2009;31(1):108-16
pubmed: 19234959
Proc Natl Acad Sci U S A. 2011 May 10;108(19):8030-5
pubmed: 21518883
Int J Immunopathol Pharmacol. 2018 Jan-Dec;32:394632017752240
pubmed: 29363375
Cell Host Microbe. 2017 Jul 12;22(1):25-37.e6
pubmed: 28704649
Clin Immunol. 2014 Jul;153(1):178-86
pubmed: 24769377
Exp Ther Med. 2015 Sep;10(3):966-972
pubmed: 26622423